p16 gene overexpression in mouse bladder carcinomas

Knowles, 1994, Allelotype of human bladder cancer, Cancer Res., 54, 531 Orlow, 1994, Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors, Cancer Res., 54, 2848 Miyao, 1993, Role of chromosome 9 in human bladder cancer, Cancer Res., 53, 4066 Cairns, 1994, Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction, Cancer Res., 54, 1422 Kamb, 1994, A cell cycle regulator potentially involved in genesis of many tumor types, Science, 264, 436, 10.1126/science.8153634 Nobori, 1994, Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers, Nature, 368, 753, 10.1038/368753a0 Serrano, 1993, A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4, Nature, 366, 704, 10.1038/366704a0 Cairns, 1995, Frequency of homozygous deletion at p16/CDKN2 in primary human tumours, Nat. Genet., 11, 210, 10.1038/ng1095-210 Ito, 1989, Promotion of urinary bladder carcinogenesis in experimental animals, Exp. Pathol., 36, 1, 10.1016/S0232-1513(89)80104-5 McCormick, 1981, Influence of total dose and dose schedule on induction of urinary bladder cancer in the mouse by N-butyl-N-(4-hydroxybutyl)nitrosamine, Carcinogenesis, 2, 251, 10.1093/carcin/2.3.251 Quelle, 1995, Cloning and characterization of murine p16INK4a and p15INK4b genes, Oncogene, 11, 635 Asamoto, 1991, Molecular mechanisms of TPA-mediated inhibition of gap-junctional intercellular communication: evidence for action on the assembly or function but not the expression of connexin 43 in rat liver epithelial cells, Mol. Carcinog., 4, 322, 10.1002/mc.2940040411 Hegi, 1994, Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation, Cancer Res., 54, 6257 Herzog, 1995, Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36, Oncogene, 11, 1811 Wiseman, 1994, Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes, Proc. Natl. Acad. Sci. USA, 91, 3759, 10.1073/pnas.91.9.3759 Linardopoulos, 1995, Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors, Cancer Res., 55, 5168 Baldin, 1993, Cyclin D1 is a nuclear protein required for cell cycle progression in G1, Genes Dev., 7, 812, 10.1101/gad.7.5.812 Jiang, 1993, Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression, Oncogene, 8, 3447 Quelle, 1993, Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts, Genes Dev., 7, 1559, 10.1101/gad.7.8.1559 Lukas, 1994, Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines, Oncogene, 9, 707 Musgrove, 1994, Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle, Proc. Natl. Acad. Sci. USA, 91, 8022, 10.1073/pnas.91.17.8022 Resnitzky, 1994, Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system, Mol. Cell. Biol., 14, 1669 Hunter, 1994, Cyclins and cancer. II: cyclin D and CDK inhibitors come of age, Cell, 79, 573, 10.1016/0092-8674(94)90543-6 Sherr, 1994, G1 phase progression: cycling on cue, Cell, 79, 551, 10.1016/0092-8674(94)90540-1 Guan, 1994, Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function, Genes Dev., 8, 2939, 10.1101/gad.8.24.2939 Jen, 1994, Deletion of p16 and p15 genes in brain tumors, Cancer Res., 54, 6353 Reznikoff, 1996, Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells, Cancer Res., 56, 2886 Lukas, 1995, Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16, Nature, 375, 503, 10.1038/375503a0 Okamoto, 1994, Mutations and altered expression of p16INK4 in human cancer, Proc. Natl. Acad. Sci. USA, 91, 11045, 10.1073/pnas.91.23.11045 Yeager, 1995, Increased p16 levels correlate with pRb alterations in human urothelial cells, Cancer Res., 55, 493 Geradts, 1995, Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression, Cancer Res., 55, 6006 He, 1994, CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines, Cancer Res., 54, 5804